Resistin levels in preterms: are they influenced by fetal inflammatory course?

T Gursoy1, D Aliefendioglu, O Caglayan

  • 1Department of Pediatrics, Zeynep Kamil Maternity and Children's Education and Training Hospital, NICU, Istanbul, Turkey. tugbagursoy@gmail.com

Insights

Resistin levels are elevated in preterm neonates with preterm prelabour rupture of membranes (PPROM) and reduced in those whose mothers received antenatal steroids, suggesting a role in fetal inflammation.

Area of Science:

  • Neonatal research
  • Inflammatory markers
  • Maternal-fetal medicine

Background:

  • Preterm delivery pathogenesis involves maternal/perinatal infections and inflammation.
  • Resistin is implicated in inflammatory cytokine cycles and neonatal growth.
  • Limited research exists on resistin's role in neonatal inflammation.

Purpose of the Study:

  • To evaluate resistin levels in premature neonates.
  • To assess the impact of preterm prelabour rupture of membranes (PPROM) on resistin levels.
  • To investigate the effect of antenatal steroid use on neonatal resistin levels.

Main Methods:

  • Included 118 preterm neonates and their mothers' medical data.
  • Measured serum resistin, IL-6, CRP, and procalcitonin in neonates within 2 hours of birth.
  • Analyzed data based on PPROM status and antenatal steroid exposure.

Main Results:

  • Babies with PPROM showed significantly higher resistin levels (70.7 ng/mL) compared to those without (25.9 ng/mL).
  • Neonates whose mothers received antenatal steroids had significantly lower resistin levels (20.8 ng/mL) than those who did not (34.6 ng/mL).
  • Resistin correlated with IL-6, procalcitonin, and CRP in neonates without antenatal steroid exposure, but not in those with exposure.

Conclusions:

  • Preterm delivery and PPROM involve complex inflammatory cascades.
  • Elevated resistin in PPROM neonates and suppressed levels with antenatal steroids suggest a role in fetal inflammation.
  • Resistin may serve as a marker for inflammatory responses in premature neonates.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...